EurOPDX
@europdx
The EurOPDX Consortium of translational and clinical researchers focuses on the use and evolution of patient-derived cancer xenograft models.
ID: 783231641422598144
http://europdx.eu 04-10-2016 09:05:49
789 Tweet
569 Followers
731 Following
🗞️ Published in Clinical Cancer Research, a VHIO-led study that shows the preclinical potential of systemic targeted therapy in pseudomyxoma peritonei. 🤝 This work was supported by the PMPnet #AcceleratorAward. ➡️ linke.to/CCRENGVHIO
This has been a great MBC Symposium. Excellent speakers and posters leading to thought-provoking discussions and networking to enhance future research collaboration. Patient advocates contributing with relevant and challenging questions. Manchester Cancer Research Centre Division of Cancer Sciences Breast Cancer Now
Big congratulations to INFRAFRONTIER. Czech Centre for Phenogenomics is proud to be part of these two initiatives. Institute of Molecular Genetics BIOCEV_SCIENCE
📣 Join us for the Emerging Leaders in Biomedicine Symposium at VHIO! Co-organized by Josep Carreras Leukaemia Research Institute (IJC), IBEC, IBMB, Centre for Genomic Regulation (CRG), IRB Barcelona, IBUB-UB, UPF Barcelona, and #VHIO. 🗓️ Register now and mark your calendars ➡️ linke.to/EmergingLeader… Pancho Barriga
Scientists at Early Cancer Institute, University of Cambridge are using a multi-disciplinary approach to understand the earliest stages of cancer and develop radical new ways to detect and treat it early. #ChangingTheStoryOfCancer Cambridge University Cambridge University Hospitals NHS Cambridge Cancer Research Hospital Science and Innovation at Cancer Research UK zurl.co/J8ox
🚀 Join the Workshop on Mouse Pathobiology with MorphoPHEN & INFRAFRONTIER from 14-16 Oct at Universitat Autònoma de Barcelona. Renowned researchers will share insights on human disease modelling, phenotyping, and more. Free registration via email to [email protected]. ℹ️bit.ly/pathobiology20…